Gene · 4256
Papers3,332
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,332
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated Multi-Omics Reveals Cellular States and Microenvironmental Remodeling in Coexisting DCIS and IDC. | Adv Sci (Weinh) | 2026 | 42801661 | PubTator, text mining | PubMed |
| Regulators of Mineralization and Long-Term Progression of Aortic Valve and Mitral Annular Calcification: MESA. | J Am Heart Assoc | 2026 | 42786596 | PubTator, text mining | PubMed |
| A Multifunctional Mesoporous Janus Separator With Optimized Mass Transport Regulation Enabling 800-Cycle Lithium-Oxygen Batteries. | Adv Sci (Weinh) | 2026 | 42733227 | PubTator, text mining | PubMed |
| Circulating matrix GLA protein during puberty in healthy and central precocious puberty children. | Endocr Connect | 2026 | 42696275 | PubTator, text mining | PubMed |
| Beyond Bone Health: Exploring the "Heart-Brain-Bone" Axis Modulated by Lipid-Soluble Nutrients (Omega-3, Vitamin D3, and Vitamin K2). | Nutrients | 2026 | 42654291 | PubTator, text mining | PubMed |
| Polyaspartic Acid-Doped With Robust Polymerized Hydrogel Armor Enhances Anti-Calcification of Decellularized Porcine Heart Valves. | Adv Healthc Mater | 2026 | 42638230 | PubTator, text mining | PubMed |
| Caspase-8 as a candidate mediator associated with everolimus resistance in neuroendocrine tumors. | J Mol Endocrinol | 2026 | 42615220 | PubTator, text mining | PubMed |
| Mitochondrial RNA modification in colorectal cancer: From single-cell analysis to machine learning-based risk modeling. | Comput Biol Chem | 2026 | 42600521 | PubTator, text mining | PubMed |
| Single-Cell atlas of aqueous humor outflow in glaucomatous Non-Human Primates identified MGP as a regulator of ECM remodeling. | Exp Eye Res | 2026 | 42562148 | PubTator, text mining | PubMed |
| From proteome-wide Mendelian randomization and multi-omics integration to functional validation: TGFB3 as a prioritized candidate in gastric adenocarcinoma. | Front Oncol | 2026 | 42518818 | PubTator, text mining | PubMed |
| Bellidifolin Improves Pulmonary Artery Smooth Muscle Cells Proliferation by Targeting the IGFBP5-Mediated PI3K-AKT-mTOR Pathway and Dilates the Pulmonary Artery. | Biomolecules | 2026 | 42509851 | PubTator, text mining | PubMed |
| Decoding early lung adenocarcinoma progression by single-cell and spatial transcriptomics reveals a CMA-related prognostic signature. | Front Immunol | 2026 | 42495647 | PubTator, text mining | PubMed |
| Core binding factor β preserves early chondrogenic identity and prevents hypertrophic transition in cartilage organoids formation. | Cell Biosci | 2026 | 42421090 | PubTator, text mining | PubMed |
| Integrative Transcriptomic Analysis and Single-Cell Validation Identify a Six-Hub-Gene Signature Converging on Inflammatory Signaling in Osteoarthritis. | Genes (Basel) | 2026 | 42353855 | PubTator, text mining | PubMed |
| Vitamin K status and vascular calcification biomarkers as determinants of carotid plaque in peritoneal dialysis: a prospective study. | Ren Fail | 2026 | 42331758 | PubTator, text mining | PubMed |
| Potentials of BMSCs for regulating osteogenic-vascular-neural-lymphatic coupling in bone regeneration. | Biomed Eng Online | 2026 | 42298623 | PubTator, text mining | PubMed |
| The dual role of extracellular vesicles in vascular calcification: from molecular mechanisms to clinical translation. | Front Cardiovasc Med | 2026 | 42181618 | PubTator, text mining | PubMed |
| A double-blind randomised controlled trial assessing the effect of menaquinone producing probiotics on vitamin K status. | Benef Microbes | 2026 | 42000184 | PubTator, text mining | PubMed |
| Spatial Mapping of the Precancer-to-Cancer Transition in Breast and Prostate. | Cancer Discov | 2026 | 41997105 | PubTator, text mining | PubMed |
| Integrated single‑cell and spatial transcriptomics reveal the colorectal cancer microenvironment. | Crit Rev Oncol Hematol | 2026 | 41933856 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4256/papers